Evidence map›Paper›PMID 28834615›Full record

ArticleHepatology (Baltimore, Md.)2018

Self-assembled liver organoids recapitulate hepatobiliary organogenesis in vitro.

Dipen Vyas, Pedro M Baptista, Matthew Brovold, Emma Moran, Brandon Gaston, Chris Booth, Michael Samuel, Anthony Atala, Shay Soker

Abstract read
In one paragraph

Article in Hepatology (Baltimore, Md.), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Advances in Engineering Human Tissue Models.Frontiers in bioengineering and biotechnology · 2020
    Pooled it
  2. Organoids of liver diseases: From bench to bedside.World journal of gastroenterology · 2019
    Pooled it
  3. Review
  4. Review
  5. Article
  6. Bioengineered Bile Duct for Liver Regenerative Medicine and Bile Duct Reconstruction.JGH open : an open access journal of gastroenterology and hepatology · 2025
    Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Generation ofRegenerative therapy · 2024
    Review
  15. Dual Deletion ofInternational journal of molecular sciences · 2024
    Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Dipen VyasWake Forest Institute for Regenerative Medicine, Wake Forest Baptist Health, Winston-Salem, NC.
Pedro M BaptistaAragon Health Research Institute (IIS Aragon), Zaragoza, Spain.
Matthew BrovoldWake Forest Institute for Regenerative Medicine, Wake Forest Baptist Health, Winston-Salem, NC.
Emma MoranWake Forest Institute for Regenerative Medicine, Wake Forest Baptist Health, Winston-Salem, NC.
Brandon GastonWake Forest Institute for Regenerative Medicine, Wake Forest Baptist Health, Winston-Salem, NC.
Chris BoothWake Forest Institute for Regenerative Medicine, Wake Forest Baptist Health, Winston-Salem, NC.
Michael SamuelMass Spectrometry Core Facility, Lipid Sciences Department, Wake Forest Baptist Health, Winston-Salem, NC.
Anthony AtalaWake Forest Institute for Regenerative Medicine, Wake Forest Baptist Health, Winston-Salem, NC.
Shay SokerWake Forest Institute for Regenerative Medicine, Wake Forest Baptist Health, Winston-Salem, NC.

Funding

Virology Research Program (Program 4)P30CA016086 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Deborah F. Tate · 1985 to 2026
$201.5M
PILOT AND FEASIBILITY STUDIESP30DK034987 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ROBERT S. SANDLER · 1985 to 2026
$30.5M
(PQB6)An Integrative Computational and Bioengineered Tissue Model of MetastasisR01CA180149 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI AGUS, DAVID B, ATALA, ANTHONY · 2013 to 2016
$2.3M
Studies in Translational Regenerative MedicineT32EB014836 · NIBIB · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI ANTHONY ATALA, Victoria Weis · 2013 to 2026
$1.7M
Fundación ARAIDInstituto de Salud Carlos III PI15/00563Marie Curie Actions-European Commission H2020-MSCA-IF-2014-660554National Institute of Health R01CA180149NCI NIH HHS P30 CA016086NCI NIH HHS R01 CA180149NIBIB NIH HHS T32 EB014836NIDDK NIH HHS P30 DK034987
6 · The paper itself

Abstract

Several three-dimensional cell culture systems are currently available to create liver organoids. In gneral, these systems display better physiologic and metabolic aspects of intact liver tissue compared with two-dimensional culture systems. However, none reliably mimic human liver development, including parallel formation of hepatocyte and cholangiocyte anatomical structures. Here, we show that human fetal liver progenitor cells self-assembled inside acellular liver extracellular matrix scaffolds to form three-dimensional liver organoids that recapitulated several aspects of hepatobiliary organogenesis and resulted in concomitant formation of progressively more differentiated hepatocytes and bile duct structures. The duct morphogenesis process was interrupted by inhibiting Notch signaling, in an attempt to create a liver developmental disease model with a similar phenotype to Alagille syndrome. Conclusion: In the current study, we created an in vitro model of human liver development and disease, physiology, and metabolism, supported by liver extracellular matrix substrata; we envision that it will be used in the future to study mechanisms of hepatic and biliary development and for disease modeling and drug screening. (Hepatology 2018;67:750-761).

Indexed as

OrganogenesisAnimalsBile DuctsCell DifferentiationCell LineageExtracellular MatrixFerretsHumansLiverOrganoidsStem Cells

Identifiers

PMID28834615
PMCPMC5825235

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.